SIRIANNI, Rosa
 Distribuzione geografica
Continente #
NA - Nord America 4.230
EU - Europa 2.642
AS - Asia 1.110
AF - Africa 100
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 13
SA - Sud America 10
AN - Antartide 1
Totale 8.119
Nazione #
US - Stati Uniti d'America 4.125
UA - Ucraina 951
DE - Germania 541
SG - Singapore 423
CN - Cina 411
IT - Italia 358
AT - Austria 331
SE - Svezia 230
TR - Turchia 113
CA - Canada 103
SN - Senegal 100
IN - India 94
FI - Finlandia 71
FR - Francia 69
BE - Belgio 26
HK - Hong Kong 23
KR - Corea 22
GB - Regno Unito 14
EU - Europa 13
NL - Olanda 13
AU - Australia 12
LT - Lituania 10
CZ - Repubblica Ceca 9
BR - Brasile 4
PH - Filippine 4
AR - Argentina 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CL - Cile 2
EE - Estonia 2
IE - Irlanda 2
IL - Israele 2
JP - Giappone 2
KG - Kirghizistan 2
MX - Messico 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
GR - Grecia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HU - Ungheria 1
ID - Indonesia 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PL - Polonia 1
RO - Romania 1
TH - Thailandia 1
Totale 8.119
Città #
Chandler 765
Jacksonville 564
San Mateo 376
Singapore 347
Boardman 333
Dearborn 276
Vienna 223
New York 182
Rende 180
Ashburn 169
Lawrence 136
Roxbury 136
Shanghai 119
Izmir 106
Dakar 100
Des Moines 88
Ottawa 87
Helsinki 71
Cambridge 70
Grafing 66
Beijing 65
Brooklyn 46
Bremen 40
Ann Arbor 37
Wilmington 37
Ogden 33
Inglewood 32
Brussels 26
Seattle 25
Pune 23
Hanover 22
Redwood City 22
Seoul 22
Guangzhou 20
San Francisco 20
Hong Kong 17
Los Angeles 16
Cosenza 14
Florence 13
Fremont 13
Houston 12
Munich 12
Toronto 12
Wuhan 12
Norwalk 11
Palermo 10
Paola 10
Melbourne 9
Nanjing 9
Bangalore 8
Hefei 7
Ningbo 7
Groningen 6
Jinan 6
Washington 6
Brno 5
Latina 5
Milan 5
Strasbourg 5
Wuxi 5
Berlin 4
Central 4
Jinhua 4
Kilburn 4
London 4
Manila 4
Rome 4
Shenyang 4
Bari 3
Bhubaneswar 3
Caserta 3
Changsha 3
Coral Springs 3
Frankfurt am Main 3
Fuzhou 3
Jiaxing 3
Newark 3
Paris 3
Santa Clara 3
Shenzhen 3
Yiwu 3
Acquappesa 2
Amsterdam 2
Bagnara Calabra 2
Baotou 2
Buenos Aires 2
Canberra 2
Caprile 2
Castrolibero 2
Catania 2
Catanzaro 2
Chennai 2
Cropani 2
Crotone 2
Grimsby 2
Hadera 2
Haikou 2
Hanoi 2
Jesi 2
Lazzate 2
Totale 5.208
Nome #
6,6A-DIHYDRO FURO[3,2-B]FURAN-2-(5H)ONE DERIVATIVES, THEIR PREPARATION AND USE FOR TREATING TUMORS 144
6-substituted carbazoles: synthesis and biological evaluation 125
Activation of GPER induces apoptosis in adrenocortical cancer (ACC) cells and controls tumor growth in vivo 107
Antioxidant activity of a mediterranean food product: "fig syrup" 103
Activation of GPER inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new the therapy for ACC 103
Antiproliferative activity of some 1,4-dimethylcarbazoles on cells that express estrogen receptors: Part i 103
A resveratrol derivative induces authophagic cell death in human breast cancer MCF-7 cell line. 103
Cyclooxygenase (Cox)-2 regulating transcriptional and post-transcriptional activation of aromatase is involved in Leydig cell tumor proliferation 101
Biological activity of 3-chloro-azetidin-2-one derivatives having interesting antiproliferative activity on human breast cancer cell lines 100
" L'attività antiproliferativa dell'oleuropeina e dell'idrossitirisolo nelle cellule di carcinoma mammario MCF-7 è associata all'inibizione delle MAP chinasi." 98
A role of Src-tyrosine kinase in adrenal aldosterone production 98
27-hydroxycholesterol promotes adrenocortical cancer progression. 95
DAX-1, as an androgen-target gene, inhibits aromatase expression: A novel mechanism blocking estrogendependent breast cancer cell proliferation 94
Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment 94
27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer 93
Activation of G-Protein-Coupled Estrogen Receptor (GPER) inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new target for ACC treatment. 93
Estrogen related receptor a (ERRa) a promising target for the therapy of adrenocortical carcinoma (ACC) 92
17 β-estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocytes-derived cell line. 90
Cholesterol as an endogenous ERRα agonist: A new perspective to cancer treatment 89
Inhibition of cholesterol synthesis by simvastatin reduces ACC growth interfering with the regulation of mitochondrial respiratory chain mediated by estrogens/estrogen receptor alpha. 87
Aromatase expression in prepuberal Sertoli cells: effects of thyroid hormone 85
Aromatase expression in prepuberal Sertoli cells: Effect of thyroid hormone 85
17β-estradiol induces expression of apoptotic markers through activation of GPR30 pathway in rat Pachytene Spermatocytes 84
17β-Estradiol activates rapid signaling pathways involved in rat pachytene spermatocytes apoptosis through GPR30 and ERα 84
Cross-talk between estrogen and IGF-II signalling in adrenocortical tumor cell proliferation. 83
Defining the pathway responsible for Leydig cell tumors: the role of IGF-I and estrogens. 83
Activation of GPER inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new the therapy for ACC 80
Statins reduce intratumor cholesterol affecting adrenocortical cancer growth 80
ERRα/PGC1-α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical cancer (ACC) 79
Cholesterol as new target for ACC therapy. 78
Ruolo dei recettori nucleari orfani SF-1, LRH-1, SHP e DAX-1 nella regolazione dell’espressione dell'aromatasi in cellule testicolari 77
17β-Estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocyte-derived cell line 77
Synthesis of a new bis(indolyl)methane that inhibits growth and induces apoptosis in human prostate cancer cells 76
Antitumoral activities of curcumin and recent advances to improve its oral bioavailability 75
A novel interplay between AR and DAX-1 controls aromatase expression in estrogen-dependent cancers 74
A role for src tyrosine kinase in regulating adrenal aldosterone production 72
Catalytic Double Cyclization Process for Antitumor Agents against Breast Cancer Cell Lines 72
ERRα/PGC1α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical carcinoma (ACC). 72
DAX-1 at the Crossroads Between Androgens and Aromatase: A Novel Mechanism in the Inhibition of Estrogen-Dependent Cancer Cell Proliferation 71
27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth 70
Cross talk of estrogen (E2) and IGF-II signalling in adrenocortical tumor cell proliferation. 70
Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol 70
Antiestrogens ICI 182,780 and 4-hydroxytamoxifen upregulate Erb expression and inhibit human adrenocortical cancer proliferation. 69
Estrogen related receptor α(ERRα) a master regulator of reprogramming cancer cells metabolism as target to inhibit growth and invasion of adrenocortical carcinoma (ACC) Università della Calabria 68
Aromatase expression in peripuberal Sertoli cells:: effect of thyroid hormone 68
XCT790 an inverse agonist of estrogen related receptor alpha (ERRalpha) inhibits cellular metabolism, motility and invasion of adrenocortical cancer cell line H295R. 68
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo 66
Derivati 6,6A-Diidrofuro[3,2-b]furan-2-(5H)onici, loro preparazione e uso nel trattamento dei tumori 66
1α,25-Dihydroxyvitamin D3 inhibits the human H295R cell proliferation by cell cycle arrest: A model for a protective role of vitamin D receptor against adrenocortical cancer 65
Steroid Receptor Signallings as Targets for Resveratrol Actions in Breast and Prostate Cancer 65
Activation of GPER inhibits growth of adrenocortical cancer (ACC) cells in vitro and in vivo suggesting a new therapy for ACC 64
Cyclooxygenase-2 (COX-2) inhibitors down-regulate aromatase expression and inhibit proliferation of tumor Leydig cells 64
Antiestrogens upregulate estrogen receptor β expression and inhibit adrenocortical H295R cell proliferation 64
Estrogen Related Receptor α (ERRα) As Potential Target for a New Adrenocortical Carcinoma (ACC) Therapy 63
The metabolic regulator estrogen-related receptor alpha as a therapeutic target in Adrenocortical Carcinoma (ACC). 63
Steroid Receptor Signaling as Targets for Resveratrol Actions in Breast and Prostate Cancer 61
Central role of estrogen receptor α in adrenocortical tumor cell proliferation. 61
Resveratrol and Its Analogs As Antitumoral Agents For Breast Cancer Treatment 57
Potential of Olive oil Phenols as chemopreventive and therapeutic agents against cancer: a review of in vitro studies 57
Oleuropeina ed idrossitirisolo attivano pathways GPER-dipendenti inducendo apoptosi in cellule tumorali mammarie SKBR3 negative per i recettori estrogenici α e β. 57
Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor leydig cell proliferation 55
Differential expression of steroidogenic factor-1/adrenal 4 binding protein and liver receptor homolog-1 (LRH-1)/fetoprotein transcription factor in the rat testis: LRH-1 as a potential regulator of testicular aromatase expression 55
Rapid estrogen signaling in spermatogenesis 54
Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation 54
G protein-coupled estrogen receptor-1 (GPER1)- and estrogen receptor α (ESR1)- dependent pathways regulate spermatocytes apoptosis. 54
Mitotane activates GPER-dependent pathways leading to apoptosis of human adrenocortical carcinoma H295R cell line. 54
Effects of tri-iodothyronine on alternative splicing events in the coding region of cytochrome P450 aromatase in immature rat Sertoli cells 53
SIRT1 is involved in adrenocortical cancer growth and motility 52
The Novel Estrogen Receptor GPR30 Mediates the Proliferative Effects Induced by 17beta-Estradiol on GC-1 Mouse Spermatogonial Cell Line 51
Inhibition of Src tyrosine kinase stimulates adrenal androgen production 51
Localization and regulation of aromatase liver receptor homologue-1 in the developing rat testis 50
GPER Signaling in Spermatogenesis and Testicular Tumors 50
Characterization of olive flower phenolic extract (OFE) and its anti-proliferative activity on MCF-7 Human Breast Cancer Cells. 50
Nandrolone and Stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation 49
Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cells 49
The novel estrogen receptor GRP30 mediates the proliferatiive effects induced by 17beta-estradiol onGC-1 mouse spermatogonial cell line 48
GPR30 mediates estradiol-proliferative effects on GC-1 mouse spermatogonial cell line through ERK/Fos activation 48
Involvment of Cyclooxygenase-2 (COX-2) in regulating estrogen-dependent Leydig cell tumor proliferation 48
Inhibition of Leydig tumor growth by Farnesoid X Receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy 48
Estrogen related receptor α(ERRα) a master regulator of reprogramming cancer cells metabolism as target to fight adrenocortical carcinoma (ACC) progression and as useful tool to determine ACC stem cell-like proprieties. 48
“Involment of orphan nuclear receptors SF-1, LRH-1, DAX-1 and SHP in regulation of aromatase expression in Leydig cells”. 48
Il complesso AP-1: un repressore del CYP17 (17a-idrossilasi) nella cellula surrenalica 47
Ruolo di COX-2 sulla proliferazione estrogeno-dipendente del tumore testicolare. 47
GPER-independent inhibition of adrenocortical cancer growth by G-1 involves ROS/Egr-1/BAX pathway 47
Foxo3a inhibits tamoxifen-resistant breast cancer progression by inducing integrin α5 expression 47
The AP-1 family member Fos blocks transcriptional activity of the nuclear receptor steroidogenic factor 1 46
Il tumore delle cellule del Leydig: il ruolo di IGF-I e degli estrogeni 46
Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells 45
Role of ERRα in ACC as potential target for new adrenocortical cancer therapy. 45
Oleuropein and hydroxytyrosol activates GPER-dependent pathways inducing apoptosis in ER-negative breast cancer cells SKBR3. 45
Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system 44
The Estrogen Related Receptor α (ERRα) inverse agonist XCT-790 reduces adrenocortical cancer (ACC) H295R cells growth in vitro and in vivo. 44
Ruolo modulatore delle proteine AP-1 nella regolazione della trascrizione del gene CYP17 (17alfa-idrossilasi) 44
Il Recettore Nucleare Orfano Liver Receptor Homologue (LRH) regola la trascrizione di geni codificanti per enzimi steroidogenici 44
The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17β-estradiol on mouse spermatogonial GC-1 cell line 44
Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers 44
Adrenocortical Carcinoma (ACC) Cells Rewire Their Metabolism to Overcome Curcumin Antitumoral Effects Opening a Window of Opportunity to Improve Treatment 43
Regulation of 17a–hydroxylase (CYP17) gene transcription: the inhibitory role of AP-1 proteins 43
Role of IGF-I and estrogens in Leydig cell tumorogenesis. 43
Gper and ESRs are expressed in rat round spermatids and mediate oestrogen-dependent rapid pathways modulating expression of cyclin B1 and Bax 43
Totale 6.775
Categoria #
all - tutte 57.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.120


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020784 0 0 0 0 0 293 68 135 56 32 141 59
2020/20211.147 165 33 130 135 14 136 18 160 117 129 10 100
2021/20221.700 9 239 10 82 203 74 17 410 18 16 189 433
2022/20231.832 244 251 126 219 252 155 14 185 195 56 73 62
2023/20241.154 119 50 77 55 67 313 38 43 77 52 40 223
2024/2025867 163 330 77 135 155 7 0 0 0 0 0 0
Totale 8.269